12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Zealand Pharma preclinical data

In vitro, ZP-GA-1 had greater solubility and physical and chemical stability than native glucagon. Specifically, ZP-GA-1 degraded by 1.8% in buffer under physiological conditions after 7 days compared to degradation...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >